MEDOF (Medios AG) Other Long-Term Liabilities: $241 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEDOF Medios AG MEDOF
88 GF Score
Price $50.00
GF Value $67.77
! 2 Warning Signs
View Full Analysis

What is Medios AG Other Long-Term Liabilities?

Medios AG MEDOF 88 Other Long-Term Liabilities is $241 Mil as of Mar. 2026. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $67.77. The stock has 2 warning signs investors should review.

Medios AG's other long-term liabilities for the quarter that ended in Mar. 2026 was $241 Mil.

Medios AG's quarterly other long-term liabilities declined from Sep. 2025 ($243 Mil) to Dec. 2025 ($57 Mil) but then increased from Dec. 2025 ($57 Mil) to Mar. 2026 ($241 Mil).

Medios AG's annual other long-term liabilities increased from Dec. 2023 ($31 Mil) to Dec. 2024 ($49 Mil) and increased from Dec. 2024 ($49 Mil) to Dec. 2025 ($57 Mil).

Medios AG Other Long-Term Liabilities Related Terms

Medios AG Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Medios AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medios AG Other Long-Term Liabilities Chart

Medios AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.64 32.51 30.60 48.95 56.94

Medios AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 252.41 247.54 242.52 56.94 240.98
MEDOF
88GF Score
Medios AG MEDOF
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medios AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $241 Mil mean?
Medios AG (MEDOF) has a Other Long-Term Liabilities of $241 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Medios AG and its competitors.
Is Medios AG's Other Long-Term Liabilities too high?
Medios AG's current Other Long-Term Liabilities is $241 Mil. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's Other Long-Term Liabilities compare to MCK and COR?
Medios AG's Other Long-Term Liabilities of $241 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Medical Distribution company?
A good Other Long-Term Liabilities depends on the Medical Distribution industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Medios AG and its competitors. Medios AG's current Other Long-Term Liabilities is $241 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current Other Long-Term Liabilities of $241 Mil. The stock's GF Value™ is $67.77, compared to a current price of $50.00 — trading 26.2% below its estimated fair value. The current Other Long-Term Liabilities is $241 Mil. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Medios AG (MEDOF), the current Other Long-Term Liabilities is $241 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medios AG (MEDOF) Overvalued in 2026?

Based on GuruFocus' analysis, Medios AG stock appears to be undervalued. The current stock price of $50.00 is trading 26.2% below its estimated GF Value™ of $67.77.

Key valuation signals for MEDOF:

  • Other Long-Term Liabilities: $241 Mil
  • GF Value™: $67.77 vs. price of $50.00 (26.2% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medios AG Business Description

Address Heidestrasse 9, Berlin, DEU, 10557
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score

Get the complete analysis for MEDOF

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$50.00
Price
$67.77
GF Value